Kalaris Therapeutics Target Price

Kalaris Therapeutics target price — quarterly history, peer benchmarks, and growth trends.

Get informed when a big investor buys or sells

+ Follow

Share Price

$3.18

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-05-14	Wedbush	$17	434.6% upside
2026-04-16	Morgan Stanley	$14	340.3% upside
2026-03-09	Raymond JamesChris Raymond	$23	623.3% upside
2025-12-23	Chardan Capital	$19	497.5% upside
2025-07-23	Piper SandlerBiren Amin	$3	5.7% downside

Kalaris Therapeutics (KLRS) FAQ

Stockcircle tracks target price for Kalaris Therapeutics (KLRS), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Target Price page is built for Kalaris Therapeutics's historical target price trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use target price as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main KLRS overview so you can move from this figure to the surrounding analysis quickly.